US › Healthcare

Caris Life Sciences, Inc. Common Stock (CAI)

US · Healthcare · Biotechnology

$16.10-1.35%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$216.2M
Revenue YoY
+78.8%
Net profit
$-510,000
Profit YoY
+99.5%
EPS
$-0.00
EPS estimate
$-0.02
Net margin
-0.2%

EPS came in at -0.00 against a street estimate of -0.02 — a beat of 91.0%.

Key statistics

Market cap
$4.61B
Forward P/E
41.2
P/B
7.46
Book value
$2.10
EPS (TTM)
$-2.76
52-week high
$42.50
52-week low
$14.19
50-day MA
$16.88
200-day MA
$21.65

Analyst view

with an average price target of $27.00.

Shareholding

Insiders
48.51%
Institutions
56.85%

Largest institutional holders

FundStake
FMR Inc10.89%
J. H. Whitney Equity Partners VI, LLC6.46%
Sixth Street Partners Management Company, L.P.5.09%
Coatue Management LLC3.47%
BRAIDWELL LP2.83%
PointState Capital LP2.60%
T. Rowe Price Investment Management,Inc.1.98%
BlackRock Inc1.72%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Caris Life Sciences, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.